{
    "paper_id": "6d122276e1a720b4ae5709324fa7eb181f0d5f61",
    "metadata": {
        "title": "",
        "authors": []
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Acute infectious nonbacterial gastroenteritis (AING) in children is a common cause of hospitalization.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "First described by Zahorsky as \"winter vomiting disease,\" it has long been assumed to be due to viral etiologies. 1 Only recent-01y with the advent of newer technologies have we been able to identify specific v~ruses in infected patients.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "Most AING has been attributed to rotavirus and Norwalk-like viruses.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "Other viruses, including corona virus~like particles, adenoviruses, astroviruses and caliciviruses may also cause AING. 2, 3 Diagnoses are made with the aid of electron microscopy (EM), immunoelectronmicroscopy, tissue culture, and a variety of serologic techniques including enzymelinked immunosorbent assay (ELISA) and radioimmunoassay (RIA). 4 Demonstration of the virus in stool along with serologic evidence of antibody in patients with gastroenteritis is strong evidence for a causative role of the virus.",
            "cite_spans": [
                {
                    "start": 120,
                    "end": 122,
                    "text": "2,",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 123,
                    "end": 124,
                    "text": "3",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "We know most about Norwalk-like viruses and rotaviruses.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "Norwalk virus and Norwalk-like viruses ire associated with gastroenteritis, usually outside the infant age group. 5 This disease has an explosive onset, short duration (24 to 48 hours), is usually self-limited and characteristically occurs in epidemics. Symptoms include yomiting, diarrhea, nausea, abdominal cramps, low-grade fever, anorexia, headache, malaise and myalgias. Mucosal lesions of the proximal small bowel are produced by the virus.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "Antibody is present in most adults, usually first appearing during late adolescence and early adult life.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "The role of antibody in immunity to reinfection is not clear.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "Diagnosis is made by immunoelectronmicroscopy.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "Radioimmunoassay can also be used.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "Neither of these techniques is available on a routine basis in most clinical settings which makes diagnosis difficult.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "Rotavirus AING is a disease of infants and young children.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "It usually occurs during cooler months in temperate climates.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "The illness is more prolonged than Norwalk-like virus AING (usually about one week) and is potentially more serious.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "Rotavirus AING results in significant morbidity and mortality in third world nations and accounts for a significant number of infant hospitalizations in the United States. 6 Most children over 2 years of age have antibody. Antibody appears to be serotype specific.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "There are at least two serotypes of rotavirus that afflict humans. 3",
            "cite_spans": [],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "Symptoms include diarrhea which is usually severeand watery; vomiting and fever may accompany the diarrhea.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "Severe dehydration may ensue resulting in hospitalization.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "The diagnosis of rotavirus AING is by EM of stool specimens.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "This method is not readily available in most settings. Alternatives include ELISA and RIA.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "Therapy for AING, regardless of viral etiology, is fluid and electrolyte replacement.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "There is not any available antiviral therapy for these infections. Prevention depends on interrupting the fecal-oral route cycle.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "Immunization against rotavirus is still in the experimental state but may be available in a few years.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "There is not yet a candidate Norwalk-virus vaccine developed.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "Acute infectious nonbacterial gastroenteritis results in high morbidity and mortality in developing nations.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "In the United States, it accounts for a significant number of infant hospitalizations as well as days lost from school or work. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "ACUTE INFECTIOUS NONBACTERIAL GASTROENTERITIS (AING)"
        },
        {
            "text": "Physicians and lay persons have become quite exercised about Acquired Immune Deficiency Syndrome (AIDS).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "See IDN, Volume 2, Number 2, page 9, for a description of this disorder. The anxiety stems, in part, from the unknown cause and mode of transmission of AIDS.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "Virtually everyone believes it is caused by an infectious agent probably transmitted by blood and/or intimate contact from/with an infected patient. This belief is enhanced by the reported instances in children who received blood or blood 9 products including those very few with hemophilia who are recipients of coagulation factors prepared from donor blood. 1 One persistent fear emphasized to me by a large number of direct inquiries is the possibility of acquisition %f AIDS from hepatitis B virus vaccine (HBVV). To some, HBVV is suspect because it is prepared from plasma donated by hepatitis B surface antigen (HBsAg) positive persons. 2 HBsAg-positive individuals are frequent in the groups also susceptible to AIDS, especially male homosexuals and persons using illicit drugs by the intravenous route. 3 Since the latter groups may have donated blood, some individuals conclude that the putative AIDS agents may have been present in blood donated for HBsAg preparation as vaccine.",
            "cite_spans": [
                {
                    "start": 643,
                    "end": 644,
                    "text": "2",
                    "ref_id": "BIBREF1"
                }
            ],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "Thus far, all that has been said is supposition, theory, anxiety and concern.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "There are many \"ifs\" included in this chain of reasoning, none of which is known for certain.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "At the present time, we can only look at the evidence and draw our own set of inferences as to the likelihood of AIDS transmission by such a product as HBVV.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "First, we are not certain AIDS is caused by an infectious agent, although this is the most likely possibility. Were it to be proved that AIDS results from a noninfectious stimulus such as immune complexes to other than an infectious agent, much of the concern would evaporate.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "If AIDS is caused by an agent, then the characteristics of that agent, its environmental stability and its mode of transmission will determine the possibility and degree of risk, if any, of acquisition by products derived from blood.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "Second, thousands of persons have received HBVV. 4 What is the AIDS experienced in this group, and, in groups of comparable risk-of-AIDS status who have not received HBVV?",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "The experience is reassuring.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "Both published and ~npubfished data suggest no risk.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "Of 442 medical staff given HBVV in original tials, none have developed AIDS in the last three years. 5 Similarly, no cases of AIDS have appeared in specific high risk vaccine groups.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "Stevens reports that of 549 male homosexuals given HBVV in 1978-79, one has developed Kaposi's sarcoma (a component of AIDS) four years later.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "Another recipient, in a second trial, developed Pneumocystis carinii pneumonia two years after vaccine receipt.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "Stevens calculates the frequency as 2.4/1000 in the vaccine groups.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "However, men who had been screened for the vaccine trial and rejected because they already had been infected with hepatitis B numbered 3646; of these, 16 cases of AIDS occurred, an incidence of 4.4/1000.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "Thus the rate is higher in the nonrecipients of HBVV in an identical risk category.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "The dual findings of no cases in low risk groups receiving HBVV and no excess in HBVV recipients in high risk groups compared to non-HBVV recipients in the same groups suggest no risk from vaccine.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "Third, the preparation and testing of HBVV is among the most rigorous of all vaccine productions.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "Knowing that the final HBVV was to be PrePared from individuals with circulating infectious hepatitis B virus and prone to other infections, the manufacturers established a production protocol that includes three different modes of \"killing\" of infectious agents; these steps are known to inactivate representative viruses of all types.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "Further, many types of isolation for infectious agents are done during and after the manufacturing process.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "No infectious agents have been isolated.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "Finally, when one views the entire mass of data, the only reasonable conclusion is that there is no demonstrable risk of acquiring AIDS from HBVV.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "The Centers for Disease Control recently reported no AIDS among 200,000 individuals who have received HBVV since its general availability in July, 1982. 4 The only two cases that have occurred were in the male homosexuals referred to above who participated in the vaccine trials prior to licensure. She had been treated elsewhere f6r her conjunctivitis, during the course of which she began to cough, at first intermittently and then with increasing hoarseness and grouped into \"sp~lls\". Severe decrease in intake and a single spell which caused her to stop breathing brought her to admission after resucitation was successful.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "Two siblings, aged 3 and 9 years, were reported to be in good health but an 18-month-old sibling had similar symptoms 7 to i0 days earlier; none of the children had received all immunizations; the 3-and 9-year-old, no DTP and the 18-month-old only one dose \"a few weeks ago.\" Initial assessment included: rapid, labored respirations at 60/minute; hypotonia; mild interstitial retractions; scattered inspiratory rales and intermittent paroxymal cough associated with cyanosis and questionable whoop.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "Within 24 hours she developed severe anoxia, respiratory distress and apneic episodes, cyanosis and marked pallor.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "She required assisted ventilation through an endotracheal tube for the next 32 days.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "During this period, she developed generalized grand mal seizures, requiring initial and maintenance phenobarbital.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "Her course was marked by need for central hyperalimentation, severe anemia, an intercurrent urinary tract infection and otitis media. Her central nervous system status was uncertain on discharge.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "She had a fluorescent antibody test positive for B. pertussis and the organism was recovered from a nasopharyngeal swab.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "During her illness adenovirus was recovered from nasopharyngeal specimen.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "Her hospital bill was $52,502.62 and professional fees were $3427.00 for a total of $55,929.62.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "HEPATITIS B VACCINE AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"
        },
        {
            "text": "We have written much about pertussis in our columns in recent months.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Analysis, Course and Comment"
        },
        {
            "text": "Rather than repeat all the facts and figures, I thought display of this case in detail would provide a personalized version of the statistics.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Analysis, Course and Comment"
        },
        {
            "text": "Both the human toll to her and her family and the cost are obvious.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Analysis, Course and Comment"
        },
        {
            "text": "Her illness conceivably was preventable had the siblings had their DTP immunizations at appropriate times. It appears as if she acquired pertussis from her 18-month-old sister.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Analysis, Course and Comment"
        },
        {
            "text": "The importance of the concomitant adenovirus is controversial.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Analysis, Course and Comment"
        },
        {
            "text": "Some experts believe that both agents contribute to a more severe expression of pertussis.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Analysis, Course and Comment"
        },
        {
            "text": "We all have cared for infants similar to this patient without positive adenovirus isolation.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Analysis, Course and Comment"
        },
        {
            "text": "In all the furor over the pros and cons of pertussis and pertussis vaccine, one forgets that the disease still occurs and can still be severe and even lethal. We report our patient as a reminder of this fact to keep the debate in perspective.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Analysis, Course and Comment"
        },
        {
            "text": "Review of our in-patient records demonstrates at least 27 infants hospitalized for pertussis in the last three years and an indeterminate number of older infants and children treated as out-patients.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Analysis, Course and Comment"
        },
        {
            "text": "Our hospitalized children ranged from 1 month to 9 months of age and the cost of hospitalization varied from as little as $400.00 to $50,000.00+. Alfred Sabin and his coworkers report on the successful immunization of children with and without maternal antibody by the use of an aerosolized nasal vaccine.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Analysis, Course and Comment"
        },
        {
            "text": "In 100% of 4-to 6-month-old and older children, with and without residual maternal antibody, inhalation of undiluted aerosolized nasal vaccine produced antibody responses.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Analysis, Course and Comment"
        },
        {
            "text": "The human diploid cell vaccine used was stabilized with 1% human albumin.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Analysis, Course and Comment"
        },
        {
            "text": "In a comparative trial, a chick embryo fibroblast vaccine containing ten times more virus stabilized with hypertonic sugar solution, but without added protein, was less successful in achieving antibody responses. Dr. Sabin's group believes that the hypertonic sugar solution may have been responsible for this lesser efficacy. His discussion notes that titers in the children of transplacentally transferred maternal antibody as high as 1:512 did not prevent an immune response with aerosolized vaccine.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Analysis, Course and Comment"
        },
        {
            "text": "Levels of this type do prevent responses after subcutaneous .injection of currently employed measles vaccines.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Analysis, Course and Comment"
        },
        {
            "text": "No immediate clinical reactions were seen in the 160 children who inhaled the aerosolized vaccine and although subsequent reactions among the 96 children who were successfully gO 1983 by Elsevier Science Publishing Co., Inc.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Analysis, Course and Comment"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Acquired immune deficiency syndrome in children",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Oleske",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "B"
                    ],
                    "last": "Minnefor",
                    "suffix": ""
                }
            ],
            "year": 1983,
            "venue": "Pediatr Infect Dis",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Letter to the Editor",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Golden",
                    "suffix": ""
                }
            ],
            "year": 1983,
            "venue": "N Engl J Med",
            "volume": "308",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "The safety of hepatitis B virus vaccine",
            "authors": [],
            "year": 1982,
            "venue": "MMWR",
            "volume": "32",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Response to Letter to the Editor",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "E"
                    ],
                    "last": "Stevens",
                    "suffix": ""
                }
            ],
            "year": 1983,
            "venue": "N Engl J Med",
            "volume": "308",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "month-old girl was hospitalized on June 12, 1982 with 16 day history of ,cough, nasal congestion and conjunctivitis.",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "Allan D. Friedman, M.D.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}